Additionally, ICA from Lactobacillus johnsonii has been shown to promote the generation of progenitor-exhausted CD8+ T cells, significantly improving the efficacy of CD8+ T cell-mediated anti-PD-1 immunotherapy across multiple cancer types (76). This evidence concerns the gene CD8A and cancer.